264049503	264049503	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
63008698	63008698	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0695748	0695748	CD	B-NP	O
|	|	CC	I-NP	O
11/6/2006	11/6/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/7/2006	6/7/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/2/2006	5/2/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
GONEY	GONEY	NNP	B-NP	O
,	,	,	O	O
EVERETT	EVERETT	NNP	B-NP	O
321-31-20-4	321-31-20-4	CD	I-NP	O
New	New	NNP	I-NP	O
York	York	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/29/06	2/29/06	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GAVALIS	GAVALIS	NNP	B-NP	O
,	,	,	O	O
BARRY	BARRY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/29/06	2/29/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	B-DNA
's	's	POS	B-NP	I-DNA
home	home	NN	I-NP	I-DNA
med	me	VBD	B-VP	I-DNA
regimen	regimen	NN	B-NP	I-DNA
PLAVIX	PLAVIX	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
ADVAIR	ADVAIR	NNP	I-NP	I-DNA
DISKUS	DISKUS	NNP	I-NP	I-DNA
250/50	250/50	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
8/21	8/21	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	B-protein
GLARGINE	GLARGINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
34	34	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
8/21	8/21	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LEVOXYL	LEVOXYL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LOSARTAN	LOSARTAN	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/11/06	7/11/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
Override	Override	NN	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/11/06	7/11/06	CD	B-NP	O
by	by	IN	B-PP	O
RIVEROLL	RIVEROLL	NNP	B-NP	O
,	,	,	O	O
ANDERSON	ANDERSON	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
051060564	051060564	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LOSARTAN	LOSARTAN	NNP	B-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/11/06	7/11/06	CD	B-NP	O
by	by	IN	B-PP	O
BURRI	BURRI	NN	B-NP	B-protein
,	,	,	O	O
FREDERIC	FREDERIC	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
618138253	618138253	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Sugar	Sugar	NNP	I-NP	O
979-172-1132	979-172-1132	CD	I-NP	O
4/17/06	4/17/06	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NN	B-NP	O
TYPE	TYPE	NN	I-NP	O
IV	IV	CD	I-NP	O
HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	I-NP	O
SMOKER	SMOKER	NN	I-NP	O
FHX	FHX	NN	I-NP	O
HTN	HTN	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
CAD	CAD	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	JJ	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
LEE	LEE	NN	I-NP	O
****	****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
49M	49M	NN	B-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
S/P	S/P	NN	B-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
DOE	DOE	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
weeks	week	NNS	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
swelling	swelling	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
90Kg	90Kg	NN	I-NP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	B-protein
admission	admission	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
or	or	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

Stopped	Stop	VBN	B-VP	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
medication	medication	NN	I-NP	O
recently	recently	RB	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
states	state	NNS	I-NP	O
too	too	RB	B-NP	O
many	many	JJ	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
copays	copay	VBZ	B-VP	O
expensive	expensive	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
n't	n't	RB	O	O
adhere	adhere	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
mentioned	mention	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
begun	begin	VBN	I-VP	O
to	to	TO	I-VP	O
consume	consume	VB	I-VP	O
more	more	JJR	B-NP	O
alcohol	alcohol	NN	I-NP	O
recently	recently	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
that	that	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
S/P	S/P	NN	B-NP	O
CABG	CABG	NN	I-NP	O
1999	1999	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
SVG	SVG	NN	I-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
PDA	PDA	NN	B-NP	O
,	,	,	O	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
D1	D1	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
LAD	LAD	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
Cath	Cath	NNP	I-NP	O
2004	2004	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DES	DES	NNP	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Hypothyroidism	Hypothyroidism	NN	B-NP	O
and	and	CC	O	O
ETOH	ETOH	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
Meds	Med	NNS	B-NP	O
last	last	JJ	B-NP	O
D/C	D/C	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81mg	81mg	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
100mcg	100mcg	CD	I-NP	O
,	,	,	O	O
SLNTG	SLNTG	NN	B-NP	B-protein
,	,	,	O	O
MVI	MVI	NN	B-NP	B-protein
,	,	,	O	O
Thiamine	Thiamine	NN	B-NP	O
,	,	,	O	O
Folic	Folic	NNP	B-NP	O
Acid	Acid	NNP	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Metformin	Metformin	NNP	B-NP	O
1gr	1gr	IN	B-PP	O
BID	BID	NNP	B-NP	O
,	,	,	O	O
Losartan	Losartan	NNP	B-NP	O
50mg	50mg	CD	I-NP	O
,	,	,	O	O
Coreg	Coreg	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
20	20	CD	I-NP	O
QHS	QHS	NNP	I-NP	O
,	,	,	O	O
Zetia	Zetia	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
97.5	97.5	CD	B-NP	O
,	,	,	O	O
100R	100R	NN	B-NP	B-protein
,	,	,	O	O
144/103	144/103	CD	B-NP	O
,	,	,	I-NP	O
22	22	CD	I-NP	O
,	,	,	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
PA.	PA.	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
12cm	12cm	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
B	B	NN	B-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
R	R	NN	I-NP	O
>	>	SYM	O	O
L	L	NNP	B-NP	O
,	,	,	O	O
PMI	PMI	NNP	B-NP	O
displaced	displace	VBD	B-VP	O
lateral	lateral	JJ	B-NP	O
,	,	,	I-NP	O
RRR	RRR	NN	I-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
,	,	,	O	O
+	+	SYM	B-NP	O
S3	S3	NN	I-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	B-protein
edema	edema	SYM	O	I-protein
****	****	SYM	B-NP	I-protein
Labs/Studies	Labs/Study	NNPS	I-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
CBC	CBC	NN	I-NP	O
and	and	CC	I-NP	O
Chem-7	Chem-7	NN	I-NP	B-protein
,	,	,	O	O
Cr-1	Cr-1	NN	B-NP	B-protein
.0	.0	CD	I-NP	I-protein
BNP	BNP	NN	I-NP	I-protein
923	923	CD	B-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
Cardiomegaly	Cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
edema	edema	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intervals	interval	NNS	B-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NN	B-NP	O
V3-6	V3-6	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unchanged	unchanged	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
6/4	6/4	CD	I-NP	O
LVEF-25	LVEF-25	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
MR	MR	NN	I-NP	O
,	,	,	O	O
TR	TR	NN	B-NP	B-protein
***	***	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
#	#	#	B-NP	O
CHF	CHF	NN	I-NP	B-protein
:	:	:	O	O
EF	EF	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
and	and	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
decompensation	decompensation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
and	and	CC	I-NP	O
dietary	dietary	JJ	I-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
last	last	JJ	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
6/4	6/4	CD	I-NP	O
90kg	90kg	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
198lbs	198lb	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
diuresed	diurese	VBD	B-VP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
to	to	TO	B-PP	O
197lbs	197lb	NNS	B-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
held	hold	VBN	B-VP	O
while	while	IN	B-SBAR	O
admitted	admit	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
currently	currently	RB	B-ADVP	O
NYHA	NYHA	NNP	B-NP	O
class	class	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
consider	consider	VB	I-VP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
spironolactone	spironolactone	NN	B-NP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
regimen	regimen	NN	I-NP	O
--	--	:	O	O
deferred	defer	VBN	B-VP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interest	interest	NN	I-NP	O
of	of	IN	B-PP	O
simplifying	simplify	VBG	B-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
regimen	regimen	NN	I-NP	O
given	give	VBN	B-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
h/o	h/o	NN	I-NP	O
non-compliance	non-compliance	NN	I-NP	O
with	with	IN	B-PP	O
too	too	RB	B-NP	O
many	many	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
lasix	lasix	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
20mg	20mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
please	please	NN	I-NP	B-protein
recheck	recheck	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
if	if	IN	B-SBAR	O
patient	patient	NN	B-NP	O
needs	need	VBZ	B-VP	O
oral	oral	JJ	B-NP	O
K	K	NN	I-NP	O
replacement	replacement	NN	I-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
-	-	HYPH	B-NP	O
started	start	VBN	I-NP	O
toprol	toprol	NN	I-NP	O
xl	xl	NN	I-NP	O
25mg	25mg	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
can	can	MD	B-VP	O
consider	consider	VB	I-VP	O
ICD	ICD	NN	B-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
EF	EF	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
restarted	restart	VBN	B-NP	O
plavix	plavix	NN	I-NP	O
per	per	IN	B-PP	O
PCP	PCP	NN	B-NP	B-cell_line
's	's	POS	B-NP	I-cell_line
rec	rec	NN	I-NP	I-cell_line
-	-	HYPH	O	O
restarting	restart	VBG	B-VP	O
lipitor	lipitor	NN	B-NP	O
for	for	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
hyperchol	hyperchol	NN	I-NP	O
,	,	,	O	O
holding	hold	VBG	B-VP	O
zetia	zetia	NN	B-NP	O
for	for	IN	B-PP	O
now	now	RB	B-ADVP	O
wanting	want	VBG	B-VP	O
to	to	TO	I-VP	O
simplify	simplify	VB	I-VP	O
regimen	regimen	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
can	can	MD	B-VP	O
restart	restart	VB	I-VP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-NP	O
#	#	#	I-NP	O
COPD	COPD	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
c/w	c/w	NN	I-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
long	long	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
hx	hx	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NNP	B-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
SOB	SOB	NN	I-NP	B-protein
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
reports	report	VBZ	B-VP	O
breathing	breathing	NN	B-NP	O
much	much	RB	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
consider	consider	NN	I-NP	O
PFTs	PFT	NNS	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
-	-	HYPH	B-NP	O
advair	advair	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
#	#	#	B-NP	O
IDDM	IDDM	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
restarted	restart	VBN	I-NP	O
pt	pt	NN	I-NP	O
on	on	IN	B-PP	O
lantus	lantus	NN	B-NP	O
insulin	insulin	NN	I-NP	O
with	with	IN	B-PP	O
insulin-aspart	insulin-aspart	JJ	B-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	O	O
held	hold	VBD	B-VP	O
metformin	metformin	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	O	O
last	last	JJ	B-NP	O
HgA1c	HgA1c	NN	I-NP	O
10.9	10.9	CD	I-NP	O
in	in	IN	B-PP	O
10/5	10/5	CD	B-NP	O
-	-	HYPH	I-NP	O
HgA1C	HgA1C	NN	I-NP	O
drawn	drawn	NN	I-NP	O
,	,	,	O	O
pending	pende	VBG	B-VP	O
-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
.	.	.	O	O

consider	consider	VB	B-VP	O
adding	add	VBG	I-VP	O
short-acting	short-acting	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
only	only	JJ	B-NP	O
lantus	lantus	NN	I-NP	O
to	to	TO	B-VP	O
simplify	simplify	VB	I-VP	O
regimen	regimen	NN	B-NP	O
.	.	.	O	O

#	#	#	B-NP	O
H	H	NN	I-NP	O
/	/	SYM	B-NP	O
O	O	NN	I-NP	O
hypothyroid	hypothyroid	NN	I-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	O
>	>	SYM	B-NP	O
50	50	CD	I-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
levoxyl	levoxyl	NN	B-NP	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
levoxyl	levoxyl	NN	I-NP	O
at	at	IN	B-PP	O
prior	prior	JJ	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
F/U	F/U	NN	I-NP	B-protein
TSH	TSH	NN	I-NP	I-protein
level	level	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
-	-	HYPH	B-ADVP	O
drew	draw	VBD	B-VP	O
fT4	fT4	NN	B-NP	O
level	level	NN	I-NP	O
as	as	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
,	,	,	O	O
pending	pende	VBG	B-VP	O
#	#	#	B-NP	O
H	H	NN	I-NP	O
/	/	SYM	B-NP	O
O	O	NN	I-NP	O
EtOH	EtOH	NN	I-NP	O
abuse	abuse	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
withdrawal	withdrawal	NN	I-NP	O
szs/DTs	szs/DT	NNS	I-NP	O
-	-	:	O	O
continue	continue	JJ	B-NP	O
MVI	MVI	NNP	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
restart	restart	VB	I-VP	O
folate/thiamine	folate/thiamine	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-NP	O
#	#	#	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
reports	report	NNS	I-NP	O
wants	want	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
DNR/DNI	DNR/DNI	NN	B-NP	O
PCP	PCP	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Portier	Portier	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
bring	bring	VBP	B-VP	O
a	a	DT	B-NP	O
copy	copy	NN	I-NP	O
of	of	IN	B-PP	O
D/C	D/C	NN	B-NP	O
sum	sum	NN	I-NP	O
to	to	TO	B-PP	O
Pcp	Pcp	NN	B-NP	O
appt	appt	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
check	check	NN	B-NP	O
K	K	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DECASAS	DECASAS	NNP	B-NP	O
,	,	,	O	O
QUINN	QUINN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JV80	JV80	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/29/06	2/29/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

